ahlam1399
09-11-2015, 07:53 PM
Amgen seeks FDA approval for monthly dosing option for Repatha
(Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49c4c741/sc/19/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ojssxDH6a0w:mSJ3gY097OE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ojssxDH6a0w:mSJ3gY097OE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ojssxDH6a0w
(Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49c4c741/sc/19/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ojssxDH6a0w:mSJ3gY097OE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ojssxDH6a0w:mSJ3gY097OE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ojssxDH6a0w:mSJ3gY097OE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ojssxDH6a0w